The Immune Conductor: Re-Evaluating Thymosin Alpha 1 in 2026In the advanced performance and clinical landscapes of 2026, the medical community has abandoned the vague, outdated concept of "boosting" the immune system—a blunt-force approach that often drives systemic inflammation. Instead, the focus has shifted entirely to Immunomodulation.At the